MK-4646 Single Ascending Dose Study and DDI in Healthy Participants
MK-4646-001
Phase 1 other active
Quick answer
MK-4646 Single Ascending Dose Study and DDI in Healthy Participants for HIV infection is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- HIV infection
- Phase
- Phase 1
- Modality
- other
- Status
- active